Mapel D - Search Results

1

Patterns of care in the management of high-risk COPD in the US (2011-2019): an observational study for the CONQUEST quality improvement program.

Kerr M, Tarabichi Y, Evans A, Mapel D, Pace W, Carter V, Couper A, Drummond MB, Feigler N, Federman A, Gandhi H, Hanania NA, Kaplan A, Kostikas K, Kruszyk M, van Melle M, Müllerová H, Murray R, Ohar J, Pollack M, Pullen R, Williams D, Wisnivesky J, Han MK, Meldrum C, Price D. Kerr M, et al. Among authors: mapel d. Lancet Reg Health Am. 2023 Jul 28;24:100546. doi: 10.1016/j.lana.2023.100546. eCollection 2023 Aug. Lancet Reg Health Am. 2023. PMID: 37545746 Free PMC article.

2

Primary mediastinal malignancies: findings in 219 patients.

Temes R, Chavez T, Mapel D, Ketai L, Crowell R, Key C, Follis F, Pett S, Wernly J. Temes R, et al. Among authors: mapel d. West J Med. 1999 Mar;170(3):161-6. West J Med. 1999. PMID: 10214103 Free PMC article.

3

Dalal AA, Shah M, D'Souza AO, Mapel DW. Dalal AA, et al. Among authors: d souza ao, mapel dw. Am J Manag Care. 2011 Mar 1;17(3):e55-65. Am J Manag Care. 2011. PMID: 21504260 Free article.

4

Functional disorders of the gastrointestinal tract: Cost effectiveness review.

Mapel DW. Mapel DW. Best Pract Res Clin Gastroenterol. 2013 Dec;27(6):913-31. doi: 10.1016/j.bpg.2013.09.003. Epub 2013 Sep 26. Best Pract Res Clin Gastroenterol. 2013. PMID: 24182611 Free article. Review.

5

Estimating the cost of COPD--a matter of perspective.

Mapel DW. Mapel DW. COPD. 2006 Dec;3(4):177-8. doi: 10.1080/15412550601009248. COPD. 2006. PMID: 17361497 No abstract available.

6

Economic evaluation of treating chronic obstructive pulmonary disease with inhaled corticosteroids and long-acting beta2-agonists in a health maintenance organization.

Gagnon YM, Levy AR, Spencer MD, Hurley JS, Frost FJ, Mapel DW, Briggs AH. Gagnon YM, et al. Among authors: mapel dw. Respir Med. 2005 Dec;99(12):1534-45. doi: 10.1016/j.rmed.2005.03.018. Respir Med. 2005. PMID: 16291076 Free article.

7

Insights into COPD comorbidities from the OLIN study and other large databases.

Mapel D. Mapel D. COPD. 2011 Dec;8(6):397-9. doi: 10.3109/15412555.2011.636555. COPD. 2011. PMID: 22149398 No abstract available.

8

Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease.

Stuart BC, Simoni-Wastila L, Zuckerman IH, Davidoff A, Shaffer T, Yang HW, Qian J, Dalal AA, Mapel DW, Bryant-Comstock L. Stuart BC, et al. Am J Geriatr Pharmacother. 2010 Oct;8(5):441-53. doi: 10.1016/j.amjopharm.2010.10.002. Am J Geriatr Pharmacother. 2010. PMID: 21335297

9

Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.

Dalal AA, Roberts MH, Petersen HV, Blanchette CM, Mapel DW. Dalal AA, et al. Int J Chron Obstruct Pulmon Dis. 2010 Dec 31;6:13-22. doi: 10.2147/COPD.S15455. Int J Chron Obstruct Pulmon Dis. 2010. PMID: 21311689 Free PMC article.

10

The health impact of undiagnosed airflow obstruction in a national sample of United States adults.

Coultas DB, Mapel D, Gagnon R, Lydick E. Coultas DB, et al. Among authors: mapel d. Am J Respir Crit Care Med. 2001 Aug 1;164(3):372-7. doi: 10.1164/ajrccm.164.3.2004029. Am J Respir Crit Care Med. 2001. PMID: 11500335

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

87 results

Search Page